The Latest Breaking News from Obesity

Pharmaceutical giant Eli Lilly and Company (LLY) is on an impressive run after winning Food and Drug Administration approval for a new eczema drug called Ebglyss. As the company expands its reach in the diabetes, obesity, and eczema markets, is it a must-have in your healthcare portfolio? Read on to…

The study found associations between a mother's history of eating disorders and pre-pregnancy body mass index (BMI) higher than the normal weight range to most of the nine psychiatric diagnoses examined in the offspring.

The growing – and sometimes secret – use of drugs containing semaglutide has had a huge impact on how we live … but where will it end?

Shifting blame to the victims of economic policy is an old trick by politicians. Now they’re using obesity to tackle joblessness

LABOUR plans to give obese and unemployed people weight-loss jabs as part of a drive to get them back into work and reduce pressure on the NHS…

Scientists say using the drugs to get people back into work could carry logistical and ethical problems

Medications like Ozempic ‘transformed’ diabetes care because they improved health outcomes, say experts

Diabetes medications have started to gain attention for something other than their intended purpose: weight loss. Originally designed to manage blood sugar levels in patients with diabetes, these medications are now proving to be effective tools in the fight against obesity. As research grows, the narrative surrounding these drugs has…

Recent data reveals that the eurozone economy has narrowly skirted a recession, showing lukewarm yet positive growth. With the EU and euro area expected to grow steadily over the next two years, investing in quality stocks like Novo Nordisk (NVO), SAP SE (SAP), and Shell plc (SHEL) could be beneficial.…